StonvexLoading…
StonvexCore line items from MSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $463.63M | $1.87B | $468.44M | $474.12M |
Operating Income | $93.01M | $371.82M | $257.93M | $163.62M |
Net Income | $71.27M | $278.92M | $69.61M | $62.77M |
EPS (Diluted) | $1.83 | $7.09 | $1.77 | $1.59 |
Total Assets | $2.56B | $2.55B | $2.55B | $2.55B |
Total Liabilities | $1.21B | $1.19B | $1.25B | $1.30B |
Cash & Equivalents | $180.16M | $165.07M | $170.00M | $146.99M |
Free Cash Flow OCF − CapEx | $65.10M | $295.43M | $189.41M | $88.93M |
Shares Outstanding | 38.73M | 38.91M | 39.15M | 39.14M |